Fairvalue-Calculator Fairvalue-Calculator
EN DE

Hyundai Pharmaceutical Co (004310) Fair Value & Analysis

Healthcare · KR · Market cap 177B KRW

Price7,150 KRW
Fair Value1,791 KRW
Upside-75.0%
Quality95/100
Evidence: Medium Range 1,343 KRW – 2,238 KRW

Fair value as of: Jun 25, 2026

Analysis

Hyundai Pharmaceutical Co (004310) currently trades at 7,150 KRW, while our model-based Fair Value estimate is 1,791 KRW — implying the stock looks roughly 75.0% overvalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: medium).

About the company

Hyundai Pharmaceutical Co., Ltd. manufactures and distributes pharmaceutical products, health food drinks, and medical devices in South Korea and internationally. The company offers a range of ETC and OTC products in various therapeutic areas, including antianginal, antibiotic, antiemetics+antinauseants, antihistamines and antiallergics, antihyperlipidemic, antihypertensive, antiplatelet agent, antitussives, cell stimulants and proliferants, central nervous system, depilatory, dermatological agent, dermatology, dietary supplements, digestive system, endocrine system, expectorants, eye tonic and vitamins, gynaecolog antifungals, gynaecologic antiseptics, hemostatics, labour inhibitors, leukotriene modulator, narcotic analgesics, NSAIDs, oestrogens, ophthalmic products, OTH.sex horm and similar, SERMS, systemic hormonal contraceptives, urogenital system depilatory, uterotonic products, various alimentary tract and metabolism products, vitamins, acne, allergy, alopecia treatment, analg…

Open the full interactive analysis →

Similar stocks

Takeda Pharmaceutical Company (TAKP34) +885% Jiangsu Hengrui Pharmaceuticals Co (600276) -44% Sun Pharmaceutical Industries Limited (SUNPHARMA) -49% Zoetis Inc (Z1TS34) -75% Hansoh Pharmaceutical Group (3692) -18% United Therapeutics Corporation (U2TH34) -79%

Frequently asked questions

Is Hyundai Pharmaceutical Co (004310) undervalued?
As of Jun 25, 2026, our model estimates a fair value of 1,791 KRW versus a price of 7,150 KRW — about −75% (overvalued). Model-based estimate, not financial advice.
What is the fair value of 004310?
Our 21-model fair value for Hyundai Pharmaceutical Co is 1,791 KRW (as of Jun 25, 2026), built from audited fundamentals. The current price is 7,150 KRW.
What is the quality score of 004310?
Hyundai Pharmaceutical Co has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.